EGFR Q787Q Polymorphism Is a Germline Variant and a Prognostic Factor for Lung Cancer Treated With TKIs

The prevalence and impact of epidermal growth factor receptor (EGFR) Q787Q polymorphism on the treatment of lung adenocarcinoma remains unclear. We retrospectively analyzed patients with stage IV lung adenocarcinoma to evaluate the prevalence of the EGFR Q787Q polymorphism and its influence on effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Wen-Jui, Yang, Sheng-Hsiung, Chung, Hsin-Pei, Yen, Chia-Te, Chen, Yen-Ting, Chang, Wei-Chin, Su, Jian, Chen, Hsuan-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978303/
https://www.ncbi.nlm.nih.gov/pubmed/35387120
http://dx.doi.org/10.3389/fonc.2022.816801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978303/
https://www.ncbi.nlm.nih.gov/pubmed/35387120
http://dx.doi.org/10.3389/fonc.2022.816801

Ejemplares similares